Micregen

Micregen Presents Groundbreaking Secretomix® Research at Global Longevity Federation Conference

Micregen, the UK-based biotechnology company pioneering stem cell secretome technology, has presented new preclinical research findings at the 4th Edition Global Longevity Federation Conference, where the company served as an Official Conference Partner. Development Director Dr. Robert Mitchell took to the virtual stage to present findings from Micregen’s newly submitted research paper on Secretomix® – […]